Anti-Asthma TDM Assay Kits Market Players:
- F. Hoffmann-La Roche Ltd.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Bio-Techne Corporation
- Svar Life Science AB
- Thermo Fisher Scientific Inc.
- Eagle Biosciences, Inc.
- Merck KGaA
- Elabscience Biotechnology Inc.
- MyBioSource Inc.
- Creative Diagnostics
- Diagnostic Automation (Cortez Diagnostics, Inc.)
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of anti-asthma TDM assay kits is evaluated at USD 23.28 billion.
The global anti-asthma TDM assay kits market size exceeded USD 22.11 billion in 2025 and is set to expand at a CAGR of over 5.9%, surpassing USD 39.22 billion revenue by 2035.
North America is expected to command the largest share by 2035 in the anti-asthma TDM assay kits market, owing to the rising prevalence of asthma across the region.
Key players in the market include F. Hoffmann-La Roche Ltd., Bio-Techne Corporation, Svar Life Science AB, Thermo Fisher Scientific Inc., Eagle Biosciences, Inc., Merck KGaA, Elabscience Biotechnology Inc., MyBioSource Inc., Creative Diagnostics, Diagnostic Automation (Cortez Diagnostics, Inc.).
